Key points are not available for this paper at this time.
Despite advances in surgical and radiation therapy techniques, the prognosis of patients with malignant gliomas remains poor. Few agents have been developed specifically for brain tumors, and the nitrosoureas remain the most active antitumor agents available. In this paper we review the chemotherapeutic and chemoradiation protocols currently being used to treat primary and recurrent gliomas in adults.
Chang et al. (Mon,) studied this question.